OVERVIEW

Clinical Competence in Breast Imaging, Interventions and Management is organized by Meetings By Mail (MBM).

Release Date: 10/1/24
CME Expiration: 9/30/27

Overview:
Reaccredited! Clinical Competence in Breast Imaging, Interventions and Management provides a complete tutorial in all modalities, diagnostic strategies and interventional considerations encountered in the modern breast imaging practice. Its fifty cases allow the participant to explore a wide range of benign and malignant disease, with special focus placed on the variety of presentations and patterns of enhancement observed on mammogram, ultrasound, MRI and tomosynthesis. This activity also expounds on the many challenges provided beyond the diagnosis, with optimal approaches for intervention and management discussed throughout. The immersive case review experience is supplemented by three insightful lectures by critically acclaimed faculty. Clinical Competence in Breast Imaging, Interventions and Management is worth 25 AMA PRA Category I Credits™ and meets all MQSA CME requirements.

Topics: Breast cancer screening, MR and Ultrasound interpretations, tomosynthesis applications, multimodal interventional procedures, core needle biopsy, BIRADS, pre and post-operative imaging, high risk lesions, screening, lymph nodes, DCIS, invasive malignancies both ductal and lobular, fibroadenomas, papillomas, benign enhancement patterns, phyllodes tumors, male and pediatric applications, radial scars and much more!

Educational Objectives:
Following this enduring material, Radiologists should be able to:
1. Determine the appropriate strategies for the analysis and treatment of breast lesions.
2. Interpret screening and diagnostic mammograms while recognizing their limitations.
3. Describe the newest guidelines for pediatric breast mass management.
4. Discuss best strategies and potential limitations for breast ultrasound and MRI exam interpretation
5. Demonstrate the value of tomosynthesis in the analysis of mammography
6. Explain best strategies for intervention and management following breast pathologic diagnosis
7. Discuss core needle biopsy techniques and useful alternatives for needle localizations.
8. Describe the appropriate follow-up for MRI-guided core biopsies.

COURSE CONTENT

Clinical Competence in Breast Imaging, Interventions and Management

ACCREDITATION & CREDITS

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Global Education Group and Meetings By Mail. Global Education Group is accredited by the ACCME to provide continuing medical education for physicians.

Global Education Group designates this enduring material for a maximum of 25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material includes 21 hours Digital Mammography, 20.75 hours Breast MR, 19.5 hours Breast Ultrasound, 4.5 hours Tomosynthesis and 11 hours Core Needle Biopsy. Cases concern multiple modalities.

All credits for this enduring material are applicable toward Self Assessment CME requirements for Maintenance of Certification with the American Board of Radiology.

25 AMA PRA Category 1 Credits™

76.75 Hours

TARGET AUDIENCE

PhysicianRadiologist

SPECIALITIES

Breast RadiologyRadiology

REFUND, CANCELLATION POLICY & DISCLAIMER

Returns/Refund Policy
Meetings By Mail is proud to have a 100% satisfaction guarantee on all programs. If you are not satisfied with the program you purchased, please note our time limit for refunds under this policy is 45 days from the date of delivery. If you would like to return an online streaming product, please contact us at support@emedevents.com to remove it from your account and initiate the refund. If you intend to return a USB Flash Drive or DVD-ROM, you must ship it back to the address below in order to receive a refund. Refunds of non-defective orders totaling $1,500 or more will be subject to a 20% processing fee. If you have already applied for CME credit for a program, a refund cannot be provided.

If you believe the product you ordered is defective, please contact us via email support@emedevents.com or phone 1(800) 828-2059. If we cannot provide a solution remotely, ship the defective product back to us and we will exchange it for a working copy immediately or provide a refund.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

The files within this enduring material activity are provided for your personal use only and may not be retransmitted or redistributed without written permission from Meetings By Mail. You may not upload any file herein to any public server, online service, network or bulletin board without prior written permission from Meetings By Mail. You may not make copies for any commercial purpose. Exporting, copying or otherwise using these materials does not grant you any ownership, right, title or other interest in trademarks or copyrights owned by Meetings By Mail or any other entity. You assume the entire risk related to your use of this data. Meetings By Mail disclaims any and all warranties, whether express or implied, including (without limitation) any implied warranties of merchantability or fitness for a particular purpose. In no event will Meetings By Mail or any entity related to the creation of this enduring material be liable to you or any third party for any direct, indirect, incidental, consequential, special or exemplary damages or lost profit resulting from any use or misuse of this data.